Results 171 to 180 of about 88,489 (340)

Renal and Cardiovascular Effects of Atrial Natriuretic Peptide in Fetal Sheep [PDF]

, 1989
Barbara Hargrave, Harriet S. Iwamoto, Abraham M. Rudolph   +2 more
openalex   +1 more source

Atrial cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala, Monika Przewłocka‐Kosmala   +1 more
wiley   +1 more source

Angiotensin receptor‐neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure

ESC Heart Failure, EarlyView.
Abstract Aims Angiotensin receptor‐neprilysin inhibitor (ARNI) therapy has demonstrated improved outcomes in heart failure with reduced ejection fraction (HFrEF). However, its benefits in patients with concomitant kidney failure undergoing replacement therapy remain uncertain. Methods and results Using the National Health Insurance Service database, we
Mi‐Hyang Jung, Dong‐Hyuk Cho, Jimi Choi, Mi‐Na Kim, Chan Joo Lee, Jung‐Woo Son, Yaeni Kim, Jong‐Chan Youn, Byung‐Su Yoo   +8 more
wiley   +1 more source

NPPA/atrial natriuretic peptide is an extracellular modulator of autophagy in the heart. [PDF]

Autophagy, 2023
Forte M, Marchitti S, Di Nonno F, Stanzione R, Schirone L, Cotugno M, Bianchi F, Schiavon S, Raffa S, Ranieri D, Fioriniello S, Della Ragione F, Torrisi MR, Carnevale R, Valenti V, Versaci F, Frati G, Vecchione C, Volpe M, Rubattu S, Sciarretta S.   +20 more
europepmc   +1 more source

Removal of atrial natriuretic peptide by perfused rabbit lungs

, 1986
Marina Queiroz do Amaral Turrin, C. N. Gillis   +1 more
openalex   +1 more source

Immuno‐haemostatic dysregulation in heart failure with preserved ejection fraction

ESC Heart Failure, EarlyView.
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) is a complex condition with partially unclear pathophysiology, in which systemic inflammation is a central contributor to changes in cardiac structure and function. The contribution of non‐traditional immune effectors—such as platelets and coagulation—remains underexplored in HFpEF ...
Giorgia D'Italia, Daniëlle M. Coenen, Titus P. Lemmens, Lloyd Brandts, Simone J. H. Wielders, Magdolna Nagy, Sanne G. J. Mourmans, Anouk Achten, Ahmad Al‐Abadi, Jerremy Weerts, Arantxa Barandiaran Aizpurua, Vanessa van Empel, Blanche Schroen, Judith M. E. M. Cosemans   +13 more
wiley   +1 more source

Plasma acidification increases atrial natriuretic peptide as measured by radioimmunoassay. [PDF]

, 1987
M. G. Buckley, Giuseppe A. Sagnella, Graham A. MacGregor   +2 more
openalex   +1 more source

Clinical endpoints in pragmatic heart failure trials: From data collection to clinical endpoint classification

ESC Heart Failure, EarlyView.
Abstract Clinical endpoint classification (CEC)—that is, evaluation of clinical events using pre‐defined criteria—is commonly conducted in clinical trial operations to ensure systematic and consistent assessment of endpoints needed to assess the intervention's safety and efficacy.
Veraprapas Kittipibul, Harriette G.C. Van Spall, William Schuyler Jones, Marat Fudim, Robert J. Mentz, Kevin Anstrom, Bertram Pitt, Patrice Desvigne‐Nickens, Jerome L. Fleg, Camilla Hage, Stefan James, Claes Held, Lars Lund, Adam DeVore   +13 more
wiley   +1 more source

Evaluation of Blood Pressure Changes Using Ambulatory Blood Pressure Monitoring (ABPM) in Children Undergoing Kidney Transplantation and its Relationship with Left Ventricular Mass Index, and Level of Serum Angiotensin and Atrial Natriuretic Peptide

مجله دانشکده پزشکی اصفهان, 2012
Background: Hypertension is a problem in patients undergoing kidney transplantation. This problem can affect renal functioning, and increase heart failure and death in these patients.
Alaleh Gheisari, Mohammad Reza Sabri, Hamid Reza Pirpiran, Shaghayegh Haghjooy Javanmard   +3 more
doaj  

Two‐year outcomes of a cardiac microcurrent device in chronic heart failure: A first‐in‐human pilot study

ESC Heart Failure, EarlyView.
Abstract Aims In heart failure patients, altered myocardial electrical fields linked to oedema may impair left ventricular function. While short‐term use of implanted microcurrent generators (C‐MIC) has shown promise, long‐term effects remain unclear.
Dragana B. Kosevic, Una Radak, Petar Vukovic, Jan D. Schmitto, Kersten Brandes, Peter Goettel, Hans‐Dirk Duengen, Elvis Tahirovic, Marija Zdravkovic, Johannes Mueller, Faouzi Kallel, Marat Fudim, Stefan D. Anker, Jesus Eduardo Rame, Miodrag Peric   +14 more
wiley   +1 more source